Human monoclonal antibodies directed in opposition to the transmembrane glycoprotein (GP41) of human immunodeficiency virus-1 (HIV-1) A way for neutralizing HIV-1 is disclosed. A most popular embodiment makes use of a novel human monoclonal antibody that binds to a conserved area of the gp41 transmembrane subunit of the virus. The antibody is…